Organizations Filed Purposes:
TO PROMOTE CANINE CANCER AWARENESS AND THE SIMILARITIES TO HUMAN CANCERS AND TO FUND EDUCATION AND CANCER RESEARCH THAT BENEFITS BOTH PETS AND PEOPLE.
THE ORGANIZATION IS FORMED FOR CHARITABLE PURPOSES, MORE SPECIFICALLY TO PROMOTE CANINE CANCER AWARENESS AND EDUCATION, AND SUPPORT CANINE CANCER RESEARCH
THE PURPOSE OF THIS STUDY IS TO DETERMINE THE ANTI-TUMOR EFFECTS, THE TOXICITY (OR LACK THEREOF), AND THE APPROPRIATE DOSE OF VEMURAFENIB IN DOGS WITH TCC. VEMURAFENIB IS A DRUG THAT KILLS TUMOR CELLS THAT HAVE A VERY PRECISE MUTATION. THE GOAL IS TO IMPROVE THE OUTLOOK FOR PET DOGS AND PEOPLE WITH CANCER.
THE PURPOSE OF THIS STUDY IS TO EVALUATE THE SAFETY AND EFFICACY OF USING AGENTS THAT MODIFY GENE EXPRESSION (6-THIOGUANINE OR AZACITIDINE) PRIOR TO STANDARD CHEMOTHERAPY.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Ginger Morgan | PRESIDENT/DI | 40 | $67,500 |
| Erich Trapp | SECRETARY | 5 | $4,810 |
| Cynthia Walko | TREASURER | 5 | $0 |
| Karyn Vasquez | DIRECTOR | 5 | $0 |
| Judithann Kosky | DIRECTOR | 5 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202043189349311889_public.xml